Task force 4. Efficacy of risk factor management

被引：42

作者：

Forrester, JS

Merz, CNB

Bush, TL

Cohn, JN

Hunninghake, DB

Parthasarathy, S

Superko, HR

机构：

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1996年 / 27卷 / 05期

关键词：

D O I：

10.1016/0735-1097(96)87732-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：991 / 1006

页数：16

共 161 条

[81] CARDIOVASCULAR RISKS - NEW INSIGHTS FROM FRAMINGHAM [J].

LEVY, D ;

KANNEL, WB .

AMERICAN HEART JOURNAL, 1988, 116 (01) :266-272

[82]

LORGERIL M, 1994, LANCET, V343, P1454

[83] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .1. PROLONGED DIFFERENCES IN BLOOD-PRESSURE - PROSPECTIVE OBSERVATIONAL STUDIES CORRECTED FOR THE REGRESSION DILUTION BIAS [J].

MACMAHON, S ;

PETO, R ;

CUTLER, J ;

COLLINS, R ;

SORLIE, P ;

NEATON, J ;

ABBOTT, R ;

GODWIN, J ;

DYER, A ;

STAMLER, J .

LANCET, 1990, 335 (8692) :765-774

[84] A PROSPECTIVE-STUDY OF ASPIRIN USE AND PRIMARY PREVENTION OF CARDIOVASCULAR-DISEASE IN WOMEN [J].

MANSON, JE ;

STAMPFER, MJ ;

COLDITZ, GA ;

WILLETT, WC ;

ROSNER, B ;

SPEIZER, FE ;

HENNEKENS, CH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (04) :521-527

[85] LONG-TERM FOLLOW-UP AFTER A CONTROLLED RANDOMIZED POST-MYOCARDIAL INFARCTION REHABILITATION PROGRAM - EFFECTS ON MORBIDITY AND MORTALITY [J].

MARRA, S ;

PAOLILLO, V ;

SPADACCINI, F ;

ANGELINO, PF .

EUROPEAN HEART JOURNAL, 1985, 6 (08) :656-663

[86] ASPIRIN VERSUS COUMADIN IN THE PREVENTION OF REOCCLUSION AND RECURRENT ISCHEMIA AFTER SUCCESSFUL THROMBOLYSIS - A PROSPECTIVE PLACEBO-CONTROLLED ANGIOGRAPHIC STUDY - RESULTS OF THE APRICOT STUDY [J].

MEIJER, A ;

VERHEUGT, FWA ;

WERTER, CJPJ ;

LIE, KI ;

VANDERPOL, JMJ ;

VANEENIGE, MJ .

CIRCULATION, 1993, 87 (05) :1524-1530

[87]

MILLER BD, 1993, CIRCULATION, V88, P363

[88]

MILLER BD, 1994, CIRCULATION, V90, P460

[89] HOME VERSUS GROUP EXERCISE TRAINING FOR INCREASING FUNCTIONAL-CAPACITY AFTER MYOCARDIAL-INFARCTION [J].

MILLER, NH ;

HASKELL, WL ;

BERRA, K ;

DEBUSK, RF .

CIRCULATION, 1984, 70 (04) :645-649

[90] EFFECTS OF ESTROGEN OR ESTROGEN/PROGESTIN REGIMENS ON HEART-DISEASE RISK-FACTORS IN POSTMENOPAUSAL WOMEN - THE POSTMENOPAUSAL ESTROGEN/PROGESTIN INTERVENTIONS (PEPI) TRIAL [J].

MILLER, VT ;

LAROSA, J ;

BARNABEI, V ;

KESSLER, C ;

LEVIN, G ;

SMITHROTH, A ;

GRIFFIN, M ;

STOY, DB ;

BUSH, T ;

ZACUR, H ;

FOSTER, D ;

ANDERSON, J ;

MCKENZIE, A ;

MILLER, S ;

WOOD, PD ;

STEFANICK, ML ;

MARCUS, R ;

AKANA, A ;

HEINRICHS, L ;

KIRCHNER, C ;

OHANLAN, K ;

RUYLE, M ;

SHEEHAN, M ;

JUDD, HL ;

GREENDALE, G ;

BAYALOS, R ;

LOZANO, K ;

KAWAKAMI, K ;

BARRETTCONNOR, E ;

LANGER, R ;

KRITZSILVERSTEIN, D ;

CARRIONPETERSEN, ML ;

CAVERO, C ;

SCHROTT, HG ;

JOHNSON, SR ;

FEDDERSEN, DA ;

KRUTZFELDT, DL ;

BENDA, JA ;

PAUERSTEIN, C ;

TRABAL, J ;

SCHENKEN, R ;

STERN, MP ;

RODRIGUEZSIFUENTES, M ;

EASTON, C ;

WELLS, HB ;

ESPELAND, M ;

HOWARD, G ;

BYINGTON, R ;

LEGAULT, C ;

SHUMAKER, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (03) :199-208

← 4 5 6 7 8 9 10 11 12 13 →